Amlodipin/valsartan/hidroklorotiazid Genepharm 5 mg/160 mg/12,5 mg filmom obložene tablete
| Name | Amlodipin/valsartan/hidroklorotiazid Genepharm 5 mg/160 mg/12,5 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-519919828 |
| Active Substance | amlodipinbesilat valsartan hidroklorotiazid |
| Composition | svaka filmom obložena tableta sadrži 5 mg amlodipina (u obliku amlodipinbesilata), 160 mg valsartana i 12,5 mg hidroklorotiazida |
| Pharmaceutical Form | Filmom obložena tableta |
| Manufacturer | Genepharm S.A., Pallini Attiki, Grčka Pharmadox Healthcare Limited, Paola PLA, Malta Pharmacare Premium Ltd., Birzebbugia, Malta |
| Marketing Authorisation Holder | Genepharm S.A., 18th km. Marathonos Ave., Pallini Attiki, Grčka |
| Marketing Authorisation Date | 05.04.2022 |
| MA Period of Validity | 05.04.2027 |
| Classification Number | UP/I-530-09/19-01/209 |
| Registration Number | 381-12-01/38-22-04 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | C09DX01 |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
